Anthony Juliano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anthony Juliano has a total of 309 co-authors. Here are the top co-authors by number of shared publications:
- Max Michael Owens
Department of Psychiatry, University of Vermont, Burlington, USA
9 shared publications - Hugh Garavan
Departments of Psychiatry and Psychology, University of Vermont, Burlington, USA
7 shared publications Hugh Garavan
Department of Psychiatry, University of Vermont, 85 South Prospect Street, Burlington, VT 05405, United States
5 shared publications- Nicholas Allgaier
University of Vermont, United States
5 shared publications - Alexandra Potter
Department of Psychiatry, University of Vermont
4 shared publications Sage Hahn
Department of Psychiatry
4 shared publications
Latest Publications
- Open Access
- 16 July 2026
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 286, 113270
Cannabis and tobacco co-use and its association with striatal brain morphometry: Leveraging data from the ENIGMA addiction working group
- 16 July 2026
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 286, 113270
Open AccessCannabis and tobacco co-use and its association with striatal brain morphometry: Leveraging data from the ENIGMA addiction working group
- Open Access
Along-Tract Microstructural Alterations Associated with Stimulant Misuse Localized using Diffusion MRI Tractometry
Diffusion brain MRI (dMRI) studies of substance use disorders have reported widespread but modest white matter (WM) microstructural alterations with limited anatomical specificity. Here, we applied segment-wise along-tract 3D tractometry to brain dMRI scans to localize fine-scale WM alterations associated with stimulant misuse using two complementary analytical frameworks: Bundle Analytics (BUAN) and Medial Tractography Analysis (MeTA). We analyzed 3D profiles of widely-used diffusion metrics across 33 major WM bundles in independent cohorts of cocaine (74 cases;58 controls) and amphetamine (22 cases;18 controls) users, testing the statistical associations with brain microstructure of pooled stimulant effects, substance-specific effects, and direct comparisons between stimulant classes. Segment-wise analyses revealed focal differences localized to specific tract segments rather than uniform differences along entire bundles. In pooled stimulant misuse, convergent findings across analysis pipelines were localized to hippocampal pathways and were consistent with altered microstructural organization. Amphetamines misuse showed a broader pattern of segment-wise differences across commissural, projection, and association pathways, involving altered axonal organization. No robust segment-wise differences were detected for cocaine misuse or between stimulant classes. These results show that WM alterations are spatially localized and reproducible across tractometry frameworks, highlighting the value of along-tract 3D mapping for improving anatomical specificity in addiction neuroimaging.
Open AccessAlong-Tract Microstructural Alterations Associated with Stimulant Misuse Localized using Diffusion MRI Tractometry
Diffusion brain MRI (dMRI) studies of substance use disorders have reported widespread but modest white matter (WM) microstructural alterations with limited anatomical specificity. Here, we applied segment-wise along-tract 3D tractometry to brain dMRI scans to localize fine-scale WM alterations associated with stimulant misuse using two complementary analytical frameworks: Bundle Analytics (BUAN) and Medial Tractography Analysis (MeTA). We analyzed 3D profiles of widely-used diffusion metrics across 33 major WM bundles in independent cohorts of cocaine (74 cases;58 controls) and amphetamine (22 cases;18 controls) users, testing the statistical associations with brain microstructure of pooled stimulant effects, substance-specific effects, and direct comparisons between stimulant classes. Segment-wise analyses revealed focal differences localized to specific tract segments rather than uniform differences along entire bundles. In pooled stimulant misuse, convergent findings across analysis pipelines were localized to hippocampal pathways and were consistent with altered microstructural organization. Amphetamines misuse showed a broader pattern of segment-wise differences across commissural, projection, and association pathways, involving altered axonal organization. No robust segment-wise differences were detected for cocaine misuse or between stimulant classes. These results show that WM alterations are spatially localized and reproducible across tractometry frameworks, highlighting the value of along-tract 3D mapping for improving anatomical specificity in addiction neuroimaging.
- Open Access
Cognitive Flexibility and Inhibition Deficits in HIV and Cocaine Dependence: Evidence from Stroop and Trail Making Tests
Objective: To better define potential executive function difficulties in individuals living with HIV but not clinically identified as having HAND, with and without mild to moderate cocaine dependence (CD), our cross-sectional study examined executive function performance on the Stroop Color-Word Test (Stroop) and the Trail Making Test (TMT) in four groups stratified by HIV and CD status. Method: We recruited 101 participants (26 HIV+/CD+; 18 HIV+/CD−; 30 HIV−/CD+; 27 HIV−/CD−). We utilized a 2 (HIV: yes/no) × 2 (Cocaine: yes/no) MANCOVA while controlling for age and premorbid intelligence on the Stroop trials (i.e., color-naming, word-reading, interference), and TMT-A and TMT-B z-scores, number of errors, and the B/A ratio. Results: HIV was associated with significantly slower performance on the Stroop Interference (p = 0.012, η2 = 0.064). CD showed a trend towards slower performance on interference trials (p = 0.061, η2 = 0.037) and was associated with significantly more errors on the Stroop Word-Reading (p = 0.028, η2 = 0.050) and Interference trials (p = 0.046, η2 = 0.041), suggestive of difficulties with inhibitory control and written language processing. There were no significant HIV × Cocaine interactions. Conclusions: Our results suggest HIV without clinically identified cognitive impairment and CD are associated with distinct and potentially overlapping executive functioning deficits, particularly for measures of inhibitory control. Notably, CD showed trend-level slowing on Stroop Interference performance, suggesting partial overlap with HIV effects. Clarifying the specific cognitive processes impacted by HIV and CD can help guide tailored interventions to improve functional outcomes in these populations.
Open AccessCognitive Flexibility and Inhibition Deficits in HIV and Cocaine Dependence: Evidence from Stroop and Trail Making Tests
Objective: To better define potential executive function difficulties in individuals living with HIV but not clinically identified as having HAND, with and without mild to moderate cocaine dependence (CD), our cross-sectional study examined executive function performance on the Stroop Color-Word Test (Stroop) and the Trail Making Test (TMT) in four groups stratified by HIV and CD status. Method: We recruited 101 participants (26 HIV+/CD+; 18 HIV+/CD−; 30 HIV−/CD+; 27 HIV−/CD−). We utilized a 2 (HIV: yes/no) × 2 (Cocaine: yes/no) MANCOVA while controlling for age and premorbid intelligence on the Stroop trials (i.e., color-naming, word-reading, interference), and TMT-A and TMT-B z-scores, number of errors, and the B/A ratio. Results: HIV was associated with significantly slower performance on the Stroop Interference (p = 0.012, η2 = 0.064). CD showed a trend towards slower performance on interference trials (p = 0.061, η2 = 0.037) and was associated with significantly more errors on the Stroop Word-Reading (p = 0.028, η2 = 0.050) and Interference trials (p = 0.046, η2 = 0.041), suggestive of difficulties with inhibitory control and written language processing. There were no significant HIV × Cocaine interactions. Conclusions: Our results suggest HIV without clinically identified cognitive impairment and CD are associated with distinct and potentially overlapping executive functioning deficits, particularly for measures of inhibitory control. Notably, CD showed trend-level slowing on Stroop Interference performance, suggesting partial overlap with HIV effects. Clarifying the specific cognitive processes impacted by HIV and CD can help guide tailored interventions to improve functional outcomes in these populations.
- 1 December 2022
- Published by American Psychological Association (APA) in Experimental and Clinical Psychopharmacology
- Vol. 30 (6) , 928-946
One-year predictions of delayed reward discounting in the adolescent brain cognitive development study.
Delayed reward discounting (DRD) refers to the extent to which an individual devalues a reward based on a temporal delay and is known to be elevated in individuals with substance use disorders and many mental illnesses. DRD has been linked previously with both features of brain structure and function, as well as various behavioral, psychological, and life-history factors. However, there has been little work on the neurobiological and behavioral antecedents of DRD in childhood. This is an important question, as understanding the antecedents of DRD can provide signs of mechanisms in the development of psychopathology. The present study used baseline data from the Adolescent Brain Cognitive Development Study (N = 4,042) to build machine learning models to predict DRD at the first follow-up visit, 1 year later. In separate machine learning models, we tested elastic net regression, random forest regression, light gradient boosting regression, and support vector regression. In five-fold cross-validation on the training set, models using an array of questionnaire/task variables were able to predict DRD, with these findings generalizing to a held-out (i.e., "lockbox") test set of 20% of the sample. Key predictive variables were neuropsychological test performance at baseline, socioeconomic status, screen media activity, psychopathology, parenting, and personality. However, models using magnetic resonance imaging (MRI)-derived brain variables did not reliably predict DRD in either the cross-validation or held-out test set. These results suggest a combination of questionnaire/task variables as antecedents of excessive DRD in late childhood, which may presage the development of problematic substance use in adolescence. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
- 1 December 2022
- Published by American Psychological Association (APA) in Experimental and Clinical Psychopharmacology
- Vol. 30 (6) , 928-946
One-year predictions of delayed reward discounting in the adolescent brain cognitive development study.
Delayed reward discounting (DRD) refers to the extent to which an individual devalues a reward based on a temporal delay and is known to be elevated in individuals with substance use disorders and many mental illnesses. DRD has been linked previously with both features of brain structure and function, as well as various behavioral, psychological, and life-history factors. However, there has been little work on the neurobiological and behavioral antecedents of DRD in childhood. This is an important question, as understanding the antecedents of DRD can provide signs of mechanisms in the development of psychopathology. The present study used baseline data from the Adolescent Brain Cognitive Development Study (N = 4,042) to build machine learning models to predict DRD at the first follow-up visit, 1 year later. In separate machine learning models, we tested elastic net regression, random forest regression, light gradient boosting regression, and support vector regression. In five-fold cross-validation on the training set, models using an array of questionnaire/task variables were able to predict DRD, with these findings generalizing to a held-out (i.e., "lockbox") test set of 20% of the sample. Key predictive variables were neuropsychological test performance at baseline, socioeconomic status, screen media activity, psychopathology, parenting, and personality. However, models using magnetic resonance imaging (MRI)-derived brain variables did not reliably predict DRD in either the cross-validation or held-out test set. These results suggest a combination of questionnaire/task variables as antecedents of excessive DRD in late childhood, which may presage the development of problematic substance use in adolescence. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
- Open Access
- 6 May 2022
- Published by Springer Nature in Translational Psychiatry
- Vol. 12 (1) , 1-9
Bayesian causal network modeling suggests adolescent cannabis use accelerates prefrontal cortical thinning
While there is substantial evidence that cannabis use is associated with differences in human brain development, most of this evidence is correlational in nature. Bayesian causal network (BCN) modeling attempts to identify probable causal relationships in correlational data using conditional probabilities to estimate directional associations between a set of interrelated variables. In this study, we employed BCN modeling in 637 adolescents from the IMAGEN study who were cannabis naïve at age 14 to provide evidence that the accelerated prefrontal cortical thinning found previously in adolescent cannabis users by Albaugh et al. [1] is a result of cannabis use causally affecting neurodevelopment. BCNs incorporated data on cannabis use, prefrontal cortical thickness, and other factors related to both brain development and cannabis use, including demographics, psychopathology, childhood adversity, and other substance use. All BCN algorithms strongly suggested a directional relationship from adolescent cannabis use to accelerated cortical thinning. While BCN modeling alone does not prove a causal relationship, these results are consistent with a body of animal and human research suggesting that adolescent cannabis use adversely affects brain development.
- 6 May 2022
- Published by Springer Nature in Translational Psychiatry
- Vol. 12 (1) , 1-9
Open AccessBayesian causal network modeling suggests adolescent cannabis use accelerates prefrontal cortical thinning
While there is substantial evidence that cannabis use is associated with differences in human brain development, most of this evidence is correlational in nature. Bayesian causal network (BCN) modeling attempts to identify probable causal relationships in correlational data using conditional probabilities to estimate directional associations between a set of interrelated variables. In this study, we employed BCN modeling in 637 adolescents from the IMAGEN study who were cannabis naïve at age 14 to provide evidence that the accelerated prefrontal cortical thinning found previously in adolescent cannabis users by Albaugh et al. [1] is a result of cannabis use causally affecting neurodevelopment. BCNs incorporated data on cannabis use, prefrontal cortical thickness, and other factors related to both brain development and cannabis use, including demographics, psychopathology, childhood adversity, and other substance use. All BCN algorithms strongly suggested a directional relationship from adolescent cannabis use to accelerated cortical thinning. While BCN modeling alone does not prove a causal relationship, these results are consistent with a body of animal and human research suggesting that adolescent cannabis use adversely affects brain development.
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S270-S271
P452. Accurate Out-of-Sample BMI Prediction From Naturalistic-Imagery fMRI Connectivity
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S270-S271
P452. Accurate Out-of-Sample BMI Prediction From Naturalistic-Imagery fMRI Connectivity
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S112
P61. Working Memory Task fMRI Connectivity: Reliability and Individual Differences
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S112
P61. Working Memory Task fMRI Connectivity: Reliability and Individual Differences
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S132
P112. Polygenic Risk for Depression Moderates an Association Between Amygdala Connectivity and Internalizing Symptomatology in Childhood
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S132
P112. Polygenic Risk for Depression Moderates an Association Between Amygdala Connectivity and Internalizing Symptomatology in Childhood
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S262
P431. The Relation Between Genetic Risk for Greater Body Mass Index (BMI) and BMIz in Children is Mediated by Reward Processing in the Rostral Anterior Cingulate
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S262
P431. The Relation Between Genetic Risk for Greater Body Mass Index (BMI) and BMIz in Children is Mediated by Reward Processing in the Rostral Anterior Cingulate